Drug
Foster 100 6 G Nexthaler
Foster 100 6 G Nexthaler: highest development phase Phase 3, developed by Chiesi Farmaceutici. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Chiesi Farmaceutici
Trials
| Drug | Phase | Indication |
|---|---|---|
| Foster 100/6µg NEXThaler NCT03453112 | Phase 3 | Asthma |
Latest
No recent events.
Follow Foster 100 6 G Nexthaler on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.